Class I - Dangerous
Cross contamination with other products.
💊
Prescription Drugs
💊 Drugs • 12,141 recalls
Class I - Dangerous
Cross contamination with other products.
Class I - Dangerous
Cross contamination with other products
buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 60687-782-01.
Amerisource Health Services
Class I - Dangerous
Failed Dissolution Specifications; the product is dissolving faster than the specified limits.
Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 08816 NDC 64980-124-60
Rising Pharma Holding
Class I - Dangerous
Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.
Class I - Dangerous
Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.
Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, NDC 16714-301-01 (vial), NDC 16714-301-10 (outer box).
Zydus Pharmaceuticals (USA)
Class I - Dangerous
Cross contamination with other products
Class I - Dangerous
Subpotent Drug: reduced efficacy for epinephrine
Class I - Dangerous
Subpotent drug: out of specification results
Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.
Dr. Reddy's Laboratories
Class I - Dangerous
Presence of foreign substance.
Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen Laboratories, LLC, Alpharetta, GA 30005, NDC 13811-708-10
Trigen Laboratories
Class I - Dangerous
Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.
Class I - Dangerous
Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.
Class I - Dangerous
CGMP Deviations: Out of Specification for Total Aerobic Microbial Count (TAMC) test for unfiltered bulk for decitabine for injection.
Class I - Dangerous
Marketed Without an Approved NDA/ANDA: Products contain undeclared sildenafil.
Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, NDC 55111-629-30
Dr. Reddy's Laboratories
Class I - Dangerous
Failed Impurities/Degradation Specifications: Related Substances
Class I - Dangerous
Marketed Without an Approved NDA/ANDA: Products contain undeclared sildenafil.
Class I - Dangerous
Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Class I - Dangerous
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Class I - Dangerous
Discoloration: Brownish tablets